Progression From Presymptomatic to Clinical Type 1 Diabetes After COVID-19 Infection.

Autor: Friedl N; Institute of Diabetes Research, Helmholtz Munich, Munich, Germany., Sporreiter M; Institute of Diabetes Research, Helmholtz Munich, Munich, Germany., Winkler C; Institute of Diabetes Research, Helmholtz Munich, Munich, Germany., Heublein A; Institute of Diabetes Research, Helmholtz Munich, Munich, Germany., Haupt F; Institute of Diabetes Research, Helmholtz Munich, Munich, Germany., Ziegler AG; Institute of Diabetes Research, Helmholtz Munich, Munich, Germany., Bonifacio E; Center for Regenerative Therapies Dresden, Technische Universität Dresden, Dresden, Germany.
Jazyk: angličtina
Zdroj: JAMA [JAMA] 2024 Aug 13; Vol. 332 (6), pp. 501-502.
DOI: 10.1001/jama.2024.11174
Databáze: MEDLINE